{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:43:57Z","timestamp":1759938237484},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.contraception.2006.08.011","type":"journal-article","created":{"date-parts":[[2006,10,4]],"date-time":"2006-10-04T11:50:52Z","timestamp":1159962652000},"page":"101-107","source":"Crossref","is-referenced-by-count":11,"title":["Serum potassium monitoring for users of ethinyl estradiol\/drospirenone taking medications predisposing to hyperkalemia: physician compliance and survey of knowledge and attitudes"],"prefix":"10.1016","volume":"75","author":[{"given":"Patricia","family":"Mona Eng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne","family":"Loughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander M.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2006.08.011_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2006.08.011_bib2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacc.2005.06.010","article-title":"The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure","volume":"46","author":"Shah","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.contraception.2006.08.011_bib3","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1525-1497.2005.0257.x","article-title":"Laboratory monitoring of drugs at initiation of therapy in ambulatory care","volume":"20","author":"Raebel","year":"2005","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.contraception.2006.08.011_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1525-1497.2005.40182.x","article-title":"Brief report: laboratory safety monitoring of chronic medications in ambulatory care settings","volume":"20","author":"Hurley","year":"2005","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.contraception.2006.08.011_bib5","unstructured":"Raebel MA, McClure DL, Simon SR, et al. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Safety [Published online Feb 8, 2006]."},{"key":"10.1016\/j.contraception.2006.08.011_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/archfami.4.1.24","article-title":"The infrequency of liver function testing in patients using nonsteroidal anti-inflammatory drugs","volume":"4","author":"Walker","year":"1995","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.contraception.2006.08.011_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/pds.1193","article-title":"FDA drug prescribing warnings: is the black box half empty of half full?","volume":"15","author":"Wagner","year":"2006","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1016\/j.contraception.2006.08.011_bib8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jama.286.7.831","article-title":"Liver enzyme monitoring in patients treated with troglitazone","volume":"286","author":"Graham","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2006.08.011_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/pds.592","article-title":"Contraindicated medications dispensed with cisapride: temporal trends in relation to the sending of \u2018Dear Doctor\u2019 letters","volume":"10","author":"Weatherby","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.contraception.2006.08.011_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.amjhyper.2004.12.003","article-title":"Effects of drospirenone\/17-\u03b2 estradiol on blood pressure and potassium balance in hypertensive postmenopausal women","volume":"18","author":"Preston","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.contraception.2006.08.011_bib11","unstructured":"Loughlin J, Seeger JD, Eng PM, Clifford RC, Cutone J, Walker AM. Risk of hyperkalemia in women taking ethinyl estradiol\/drospirenone and other oral contraceptives [submitted for publication]."}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782406003301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782406003301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T17:26:04Z","timestamp":1547313964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782406003301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0010782406003301"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2006.08.011","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}